ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical TrialsHillary S. Andrews, Jeff Allen, Adam Rosenthal et al.|Clinical Cancer Research|2025Cited by 19
Data from ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical TrialsHillary S. Andrews, Jeff Allen, Névine Zariffa et al.|Unknown|2025Cited by 0
Supplementary Table S1 from ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical TrialsHillary S. Andrews, Jeff Allen, Névine Zariffa et al.|Unknown|2025Cited by 0
Supplementary Figure S5 from ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical TrialsHillary S. Andrews, Jeff Allen, Névine Zariffa et al.|Unknown|2025Cited by 0
Supplementary Figure S1 from ctDNA Clearance as an Early Indicator of Improved Clinical Outcomes in Advanced NSCLC Treated with TKI: Findings from an Aggregate Analysis of Eight Clinical TrialsHillary S. Andrews, Jeff Allen, Névine Zariffa et al.|Unknown|2025Cited by 0